OpenEvidence acquires Amaro, an AI-driven advertising startup co-founded by Kush Khosla and Sauren Khosla. The company specializes in AI-native ad solutions and has raised backing from Google Ventures and Greycroft. This move expands OpenEvidence’s capabilities in AI-powered advertising technology.
OpenEvidence, a medical search and AI platform for clinicians, acquires Amaro, an AI-driven advertising company. Amaro was founded by Kush and Sauren Khosla and previously secured backing from Google Ventures and Greycroft.
OpenEvidence acquires Amaro, an AI-focused advertising firm backed by Google Ventures and Greycroft. The move aims to integrate Amaro’s AI capabilities into OpenEvidence’s existing medical search and AI platform for clinicians. Amaro specializes in AI-driven advertising solutions, potentially expanding OpenEvidence’s reach beyond healthcare into broader AI applications.
OpenEvidence acquires **Amaro**, an AI-powered advertising startup. The company was backed by **Google Ventures** and **Greycroft**. Amaro specializes in leveraging artificial intelligence to optimize ad performance and targeting.
OpenEvidence has acquired Amaro, an AI-focused advertising company co-founded by Kush Khosla and Sauren Khosla. The startup was backed by investors including Google Ventures and Greycroft. Amaro specializes in AI-driven advertising solutions.
Amaro
Amaro was an AI-native advertising firm that consolidated ad analytics across ad accounts before OpenEvidence acquired it.